Endoscopic techniques for treating gastroesophageal reflux

Juan Reyes Genere, Kenneth Ke Ning Wang

Research output: Contribution to journalArticle

Abstract

Purpose of review Nearly, a third of patients with medically refractory gastroesophageal reflux disease (GERD) will desire an additional nonsurgical treatment option. Recently, endoscopic therapy has been reintroduced as a minimally invasive antireflux barrier treatment, after addressing prior efficacy and safety concerns. Over the last two decades, additional experience and new technologies have resulted in devices and protocols with favorable short-term outcomes and safety profiles. The current literature in endoscopic antireflux therapies covers new devices, long-term follow-up data and further safety experience. This review discusses the endoscopic antireflux devices on the market and most recent studies in this area. Recent findings Quality of life and reflux symptom score improvement is observed in 73–90% of patients through a 36–48 month follow-up period, with 41–77% remaining off all reflux medicines. Composite data from several thousand cases indicate a low rate (0.93–2.4%) of serious complications and no late adverse effects, including gas-bloat syndrome. Summary In this review, we describe the four endoscopic antireflux devices on market and summarize the current data in the literature. The short and long-term data demonstrate durable symptom improvement and favorable safety profile. Endoscopic antireflux treatment should be considered in the management of GERD.

Original languageEnglish (US)
Pages (from-to)288-294
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume34
Issue number5
DOIs
StatePublished - Jan 1 2018

Fingerprint

Gastroesophageal Reflux
Safety
Equipment and Supplies
Therapeutics
Quality of Life
Technology

Keywords

  • Antireflux therapy
  • Endoscopic plication
  • Gastroesophageal reflux disease endotherapy
  • Minimally invasive
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Endoscopic techniques for treating gastroesophageal reflux. / Genere, Juan Reyes; Wang, Kenneth Ke Ning.

In: Current Opinion in Gastroenterology, Vol. 34, No. 5, 01.01.2018, p. 288-294.

Research output: Contribution to journalArticle

@article{9834a3795de84a0f942e91f9cac755a7,
title = "Endoscopic techniques for treating gastroesophageal reflux",
abstract = "Purpose of review Nearly, a third of patients with medically refractory gastroesophageal reflux disease (GERD) will desire an additional nonsurgical treatment option. Recently, endoscopic therapy has been reintroduced as a minimally invasive antireflux barrier treatment, after addressing prior efficacy and safety concerns. Over the last two decades, additional experience and new technologies have resulted in devices and protocols with favorable short-term outcomes and safety profiles. The current literature in endoscopic antireflux therapies covers new devices, long-term follow-up data and further safety experience. This review discusses the endoscopic antireflux devices on the market and most recent studies in this area. Recent findings Quality of life and reflux symptom score improvement is observed in 73–90{\%} of patients through a 36–48 month follow-up period, with 41–77{\%} remaining off all reflux medicines. Composite data from several thousand cases indicate a low rate (0.93–2.4{\%}) of serious complications and no late adverse effects, including gas-bloat syndrome. Summary In this review, we describe the four endoscopic antireflux devices on market and summarize the current data in the literature. The short and long-term data demonstrate durable symptom improvement and favorable safety profile. Endoscopic antireflux treatment should be considered in the management of GERD.",
keywords = "Antireflux therapy, Endoscopic plication, Gastroesophageal reflux disease endotherapy, Minimally invasive, Radiofrequency ablation",
author = "Genere, {Juan Reyes} and Wang, {Kenneth Ke Ning}",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/MOG.0000000000000468",
language = "English (US)",
volume = "34",
pages = "288--294",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Endoscopic techniques for treating gastroesophageal reflux

AU - Genere, Juan Reyes

AU - Wang, Kenneth Ke Ning

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose of review Nearly, a third of patients with medically refractory gastroesophageal reflux disease (GERD) will desire an additional nonsurgical treatment option. Recently, endoscopic therapy has been reintroduced as a minimally invasive antireflux barrier treatment, after addressing prior efficacy and safety concerns. Over the last two decades, additional experience and new technologies have resulted in devices and protocols with favorable short-term outcomes and safety profiles. The current literature in endoscopic antireflux therapies covers new devices, long-term follow-up data and further safety experience. This review discusses the endoscopic antireflux devices on the market and most recent studies in this area. Recent findings Quality of life and reflux symptom score improvement is observed in 73–90% of patients through a 36–48 month follow-up period, with 41–77% remaining off all reflux medicines. Composite data from several thousand cases indicate a low rate (0.93–2.4%) of serious complications and no late adverse effects, including gas-bloat syndrome. Summary In this review, we describe the four endoscopic antireflux devices on market and summarize the current data in the literature. The short and long-term data demonstrate durable symptom improvement and favorable safety profile. Endoscopic antireflux treatment should be considered in the management of GERD.

AB - Purpose of review Nearly, a third of patients with medically refractory gastroesophageal reflux disease (GERD) will desire an additional nonsurgical treatment option. Recently, endoscopic therapy has been reintroduced as a minimally invasive antireflux barrier treatment, after addressing prior efficacy and safety concerns. Over the last two decades, additional experience and new technologies have resulted in devices and protocols with favorable short-term outcomes and safety profiles. The current literature in endoscopic antireflux therapies covers new devices, long-term follow-up data and further safety experience. This review discusses the endoscopic antireflux devices on the market and most recent studies in this area. Recent findings Quality of life and reflux symptom score improvement is observed in 73–90% of patients through a 36–48 month follow-up period, with 41–77% remaining off all reflux medicines. Composite data from several thousand cases indicate a low rate (0.93–2.4%) of serious complications and no late adverse effects, including gas-bloat syndrome. Summary In this review, we describe the four endoscopic antireflux devices on market and summarize the current data in the literature. The short and long-term data demonstrate durable symptom improvement and favorable safety profile. Endoscopic antireflux treatment should be considered in the management of GERD.

KW - Antireflux therapy

KW - Endoscopic plication

KW - Gastroesophageal reflux disease endotherapy

KW - Minimally invasive

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=85056484965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056484965&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000468

DO - 10.1097/MOG.0000000000000468

M3 - Article

VL - 34

SP - 288

EP - 294

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 5

ER -